GlassScriptPhysician profile
George Skaf
NPI 1396205035
$5,357.11
in general payments reported to CMS, 2019-2025
26 companies · $1,339 in 2025
The $1,339 reported for 2025 was more than what 89% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $115 · 2022: $448 · 2023: $1,972 · 2024: $1,484 · 2025: $1,339.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,658 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,657.89 |
| Education | $137.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shockwave Medical, INC | $998.11 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $711.09 | 2024-2025 | Lifevest |
| Abiomed | $454.29 | 2023-2025 | Impella |
| Inari Medical, INC. | $425.98 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Abbott Laboratories | $387.53 | 2023-2025 | Navitor, Mitraclip, Perclose Prostyle |
| Boston Scientific Corporation | $336.85 | 2022-2025 | Watchman Flx, Varithena Administration Pack |
| Genzyme Corporation | $306.72 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $285.42 | 2023-2024 | Opsumit, Uptravi |
| Astrazeneca Pharmaceuticals LP | $175.07 | 2022-2025 | Farxiga |
| Stryker Corporation | $162.60 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Amgen INC. | $147.38 | 2022-2024 | Repatha |
| Medical Device Business Services, INC. | $137.01 | 2023 | |
| Janssen Pharmaceuticals, INC | $129.25 | 2023-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $114.33 | 2022-2025 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $111.26 | 2023 | Camzyos |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Scpharmaceuticals INC. | $71.52 | 2023-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $71.22 | 2024-2025 | Jardiance |
| Pfizer INC. | $38.42 | 2023 | |
| Cardiva Medical, INC. | $30.53 | 2024 | Cardiva Vascade 6/7f Vcs |
| Lexicon Pharmaceuticals, INC. | $28.83 | 2023 | Inpefa |
| Kestra Medical Technology Services, INC. | $26.89 | 2023 | Assure Wcd |
| Terumo Medical Corporation | $22.07 | 2023 | Tr Band |
| Lantheus Medical Imaging, INC. | $19.34 | 2022 | |
| Medtronic, INC. | $18.17 | 2023 | |
| Novo Nordisk INC | $17.63 | 2024 | Wegovy |
| Cardiovascular Systems INC. | $15.00 | 2023 | Diamondback Coronary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Skaf listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.